Independent predictors for primary non-function after liver transplantation

Yonsei Medical Journal

Volumn 45, Issue 6, 2004, Pages 1155-1161

  Oh, Chang Kwon ^a   Sawyer, Robert G ^b   Pelletier, Shawn J ^c   Pruett, Timothy L ^b   Sanfey, Hilary A ^b  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Liver transplantation; Primary non function; Risk factor

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DONOR; FEMALE; GENDER; GRAFT FAILURE; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNE RESPONSE; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PORTAL VEIN; PREDICTION; PREOPERATIVE PERIOD; PROTHROMBIN TIME; RACE DIFFERENCE; RECIPIENT; REOPERATION; RETROSPECTIVE STUDY; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VEIN RECONSTRUCTION;

EID: 12344271107     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.6.1155     Document Type: Article

References (49)

1. Shaw BW, Gordon RD, Iwatsuki S, Starzl TE. Hepatic retransplantation. Transplant Proc 1985;17:264-71.
2. Greig PD, Woolf GM, Abecassis M, Strasberg SM, Taylor B, Superina RA, et al. Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival. Transplant Proc 1989;21:2385-8.
3. D'Alessandro AM, Ploeg RJ, Knechtle SJ, Pirsch JD, Stegall MD, Hoffmann R, et al. Retransplantation of the liver: a seven-year experience. Transplantation 1993;55: 1083-7.
4. Avolio AW, Agnes S, Pelosi G, Sollazzi L, Magalini SC, Gozzo ML, et al. Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation. Transplant Proc 1991;23:2263-5.
5. Quiroga J, Colina I, Demetris AJ, Starzl TE, Van Thiel DH. Cause and timing of first allograft failure in orthotopic liver transplantation: a study of 177 consecutive patients. Hepatology 1991;14:1054-62.
6. Colquhoun SD, Busuttil RW. Graft failure: cause, recognition, and treatment. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the liver. Philadelphia: Saunders; 1996. p.607.
7. Prium J, Van Woerden WF, Knol E, Klompmaker IJ, De Bruijn KM, Persijn GG, et al. Donor data in liver grafts with primary non-function- a preliminary analysis by the European Liver Registry. Transplant Proc 1989;21: 2383-4.
8. Mimeault R, Grant D, Ghent C, Duff J, Wall W. Analysis of donor and recipient variables and early graft function after orthotopic liver transplantation. Transplant Proc 1989;21:3355.
9. Kamath GS, Plevak DJ, Weisner RH, Rettke SR, Myers B, Ludwig J, et al. Primary nonfunction of the liver graft: when should we retransplant? Transplant Proc 1991;23:1954.
10. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991;51:157-63.
11. Kennedy EM, Wood RP, Shaw BW. Primary nonfunction: is there a contribution from the back table bath? Transplantation 1991;49:739-43.
12. Busuttil RW, Shaked A, Millis JM, Jurim O, Colquhoun SD, Shackleton CR, et al. One thousand liver transplants: the lessons learned. Ann Surg 1994;219:490-9.
13. Greig PD, Woolf GM, Abecassis A, Forster J, Strasberg SM, Taylor BR, et al. Prostaglandin E1 for primary nonfunction following liver transplantation. Transplant Proc 1989;21:3360-1.
14. Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, et al. Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation 1989;48:447-53.
15. Briegel J, Haller M, Zulke C, Kilger E, Pratschke E, Jauch KW, et al. Primary graft nonfunction following orthotopic liver transplantation: treatment with prostacyclin. Transplant Proc 1992;24:2693-5.
16. Isai H, Sheil R, McCaughan G, Dolan P, Waugh R. Successful reversal of primary graft non-function in a liver transplant patient treated with prostaglandin E1. Aust N Z Surg 1992;62:314-6.
17. Shaw BW, Wood RP. Improved results with retransplantation of the liver. Transplant Proc 1989; 21: 2407-8.
18. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993;55:807-13.
19. Emre S, Schwarz ME, Altaca G, Sethi P, Fiel I, Guy SR, et al. Safe use of hepatic allograft from donors older than 70 years. Transplantation 1996;62:62-5.
20. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation 1990;49:377-81.
21. Alexander JW, Vaughn WK. The use of "marginal" donors for organ transplantation: influence of donor age on outcome. Transplantation 1991;51:135-41.
22. Mor E, Klintmalm GB, Gonwa TA, Solomon H, Holman MJ, Gibbs JF, et al. The use of marginal donors for liver transplantation: a retrospective study of 365 liver donors. Transplantation 1992;53:383-6.
23. Makowka L, Gordon RD, Todo S, Ohkohchi N, Marsh JW, Tzakis AG, et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987;19:2378-82.
24. Ericzon BG, Lundgren G, Wilczek H, Groth CG. Experience with human liver grafts obtained after donor cardiac standstill. Transplant Proc 1987;19:3862-3.
25. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903-5.
26. Adam R, Reynes M, Johann M, Morino M, Astarcioglu I, Kafetzis I, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991;23:1538-40.
27. Teramoto K, Bowers JL, Khettry U, Palomba JD, Clouse ME. A rat fatty liver transplant model. Transplantation 1993;55:737-41.
28. Ferrell L, Bass N, Roberts J, Ascher N. Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis. J Clin Pathol 1992;45:1109-10.
29. Hayashi M, Tokunaga Y, Fujita T, Tanaka K, Yamaoka Y, Ozawa K. The effects of cold preservation on steatotic graft viability in rat liver transplantation. Transplantation 1993;56:282-7.
30. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 1991;23:1536-7.
31. D'Alessandro AM, Kalayoglu M, Sollinger HW, Pirsch JD, Southard JH, Belzer FO. Current status of organ preservation with Univeristy of Wisconsin solution. Arch Pathol Lab Med 1991;115:306-10.
32. Todo S, Nery J, Yanaga K, Podesta L, Gordon RD, Starzl TE. Extended preservation of human grafts with UW solution. JAMA 1989;261:711-4.
33. Furukawa H, Todo S, Imventarza O, Casavilla A, Wu YM, Scotti-Foglieni C, et al. Effect on cold ischemic time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991;51: 1000-4.
34. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988;45: 673-6.
35. Boudjema K, Lindell SL, Southard JH, Belzer FO. The effects of fasting on the quality of liver preservation by simple cold storage. Transplantation 1990;50:943-8.
36. Morgan GR, Sanabria JR, Clavien PA, Phillips MJ, Edwards C, Harvey PRC, et al. Correlation of donor nutritional status with sinusoidal lining cell viability and liver function in the rat. Transplantation 1991;51: 1176-83.
37. Sumimoto R, Southard JH, Belzer FO. Livers from fasted rats acquire resistance to warm and cold ischemia injury. Transplantation 1993;55:728-32.
38. Miyata T, Todo S, Imventarza O, Ueda Y, Furukawa H, Starzl TE. Endogenous endotoxemia during orthotopic liver transplantation in dogs. Transplant Proc 1989;21: 3861-2.
39. Yokoyama I, Todo S, Miyata T, Selby R, Tzakis AG, Starzl TE. Endotoxemia and human liver transplantation. Transplant Proc 1989;21:3833-41.
40. Kurose I, Kato S, Ishii H, Fukumura D, Miura S, Suematsu M, et al. Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver. Hepatology 1993;18:380-8.
41. Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: an overview and synthesis of current studies. Transplantation 1992; 53:957-78.
42. Harihara Y, Sanjo K, Idezuki Y. Cyclosporine hepatotoxicity and cold ischemia liver damage. Transplant Proc 1992;24:1984.
43. Esquivel CO, Jaffe R, Gordon RD, Iwatsuki S, Shaw BW, Starzl TE. Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis 1985;5:369-74.
44. Avolio AW, Agnes S, Chirico ASA, Castagneto M. Primary dysfunction after liver transplantation: donor or recipient fault? Transplant Proc 1999;31:434-6.
45. Pillay P, Van Thiel DH, Gavaler JS, Starzl TE. Effect of race upon organ donation and recipient survival in liver transplantation. Dig Dis Sci 1990;35:1391-6.
46. Eckhoff DE, McGuire BM, Young CC, Frenette L, Hudson SL, Contreras J, et al. Race is not a critical factor in orthotopic liver transplantation. Transplant Proc 1997;29:3729-30.
47. Devlin JJ, O'Grady JG, Tan KC, Caine RY, Williams R. Ethnic variation in patient and graft survival after liver transplantation: identification of a new risk factor for chronic allograft rejection. Transplantation 1993;56: 1381-4.
48. Gonzalez EM, Garcia IG, Sanz RG, Gonzales-Pinto L Segurola CL, Romero CJ. Liver transplantation in patients with thrombosis of the portal, splenic or superior mesenteric vein. Br J Surg 1993;80:81-5.
49. Lerut J, Tzakis AG, Bron K, Gordon RD, Iwatsuki S, Esquivel CO, et al. Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 1987;205:404-14.